BELLS HEALTHCARE — Tamoxifen Importer Profile
Pharmaceutical Importer · #5 buyer for Tamoxifen · $378.5K import value · 13 shipments · UNITED KINGDOM · DGFT Verified
BELLS HEALTHCARE is the #5 importer of Tamoxifen from India with $378.5K in import value and 13 verified shipments. BELLS HEALTHCARE holds a 2.8% market share in Tamoxifen imports based in UNITED KINGDOM. The company sources from 2 verified suppliers across 4 formulations shipped to 1 country. Overall, BELLS HEALTHCARE imports 4 pharmaceutical products worth $11.9M across 4 therapeutic categories.
BELLS HEALTHCARE — Tamoxifen Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Tamoxifen to BELLS HEALTHCARE?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $249.5K | 9 | 65.9% |
| STERIL GENE LIFE SCIENCES PRIVATE LIMITED | $129.0K | 4 | 34.1% |
BELLS HEALTHCARE sources Tamoxifen from 2 verified Indian suppliers based on 13 customs records. The primary supplier is STERIL-GENE LIFE SCIENCES PRIVATE LIMITED accounting for 65.9% of imports.
How Does BELLS HEALTHCARE Compare to Nearest Tamoxifen Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | AUROBINDO PHARMA USA INC | UNITED STATES | $1.2M | 25 | $47.3K |
| 4 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.1M | 23 | $50.0K |
| 5 | BELLS HEALTHCARE ★ | UNITED KINGDOM | $416.4K | 13 | $32.0K |
| 6 | WOCKHARDT UK LIMITED | UNITED KINGDOM | $409.8K | 9 | $45.5K |
| 7 | TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $404.1K | 14 | $28.9K |
BELLS HEALTHCARE ranks #5 among 377 Tamoxifen importers from India. Average shipment value of $32.0K compared to the market average of $23.5K. The closest competitors by value are AUROBINDO PHARMA USA INC and AUROLOGISTICS LLC, (AUROBINDO PHARM.
Where Does BELLS HEALTHCARE Import Tamoxifen To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $378.5K | 13 | 100.0% |
BELLS HEALTHCARE imports Tamoxifen to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $378.5K.
What Tamoxifen Formulations Does BELLS HEALTHCARE Import?
| Formulation | Value | Shipments |
|---|---|---|
| TAMOXIFEN 20 MG TABLETS (3X10`S) | $163.9K | 5 |
| TAMOXIFEN 20 MG TABLETS 3X10 S | $129.0K | 4 |
| TAMOXIFEN 20 MG TABLETS (3X10`S)NOS | $57.5K | 3 |
| TAMOXIFEN 20 MG TABLETS (32630X3X10) | $28.1K | 1 |
BELLS HEALTHCARE imports 4 distinct Tamoxifen formulations from India. The top formulation is TAMOXIFEN 20 MG TABLETS (3X10`S) with 5 shipments worth $163.9K.
Regulatory Requirements: Importing Tamoxifen into United Kingdom
What BELLS HEALTHCARE and other importers must comply with to import Tamoxifen from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Tamoxifen
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Tamoxifen from India and How Much Does BELLS HEALTHCARE Import?
India exported $8.9M worth of Tamoxifen through 3,139 shipments from 220 suppliers to 104 countries, serving 377 buyers globally. BELLS HEALTHCARE imports $378.5K of this total, accounting for 2.8% of India's Tamoxifen exports with 13 shipments from UNITED KINGDOM. This is verified from 13 customs shipment records covering 4 distinct formulations.
What Is the Average Order Value for BELLS HEALTHCARE's Tamoxifen Imports?
BELLS HEALTHCARE's average Tamoxifen order value is $29.1K per consignment, based on 13 shipments totaling $378.5K. BELLS HEALTHCARE is based in UNITED KINGDOM and ranks #5 among all Tamoxifen importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Tamoxifen to BELLS HEALTHCARE?
BELLS HEALTHCARE sources Tamoxifen from 2 verified Indian suppliers: STERIL-GENE LIFE SCIENCES PRIVATE LIMITED ($249.5K, 65.9%), STERIL GENE LIFE SCIENCES PRIVATE LIMITED ($129.0K, 34.1%). This is based on 13 customs records.
How Does BELLS HEALTHCARE Compare to Other Tamoxifen Importers?
BELLS HEALTHCARE ranks #5 among 377 Tamoxifen importers from India with a 2.8% market share. The top 3 importers are AUROBINDO PHARMA USA., INC, ($2.5M), ALIUD PHARMA GMBH ($1.3M), AUROBINDO PHARMA USA INC ($1.2M). BELLS HEALTHCARE processed 13 shipments from UNITED KINGDOM.
About BELLS HEALTHCARE
BELLS HEALTHCARE imports 4 products worth $11.9M. Beyond Tamoxifen, top products include Prednisolone, Paracetamol, Clopidogrel. View the complete BELLS HEALTHCARE profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tamoxifen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tamoxifen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BELLS HEALTHCARE matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BELLS HEALTHCARE's capped import value divided by total capped export value for Tamoxifen across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching BELLS HEALTHCARE importing Tamoxifen, covering 4 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tamoxifen Import Data for BELLS HEALTHCARE
Access order-level details, pricing data, supplier connections, and competitive analysis for BELLS HEALTHCARE's Tamoxifen imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BELLS HEALTHCARE
Full Company Profile →
4 products · $11.9M total trade · 4 categories
BELLS HEALTHCARE × Tamoxifen
Verified from customs records
Company Overview
Top Products by BELLS HEALTHCARE
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BELLS HEALTHCARE.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tamoxifen. For current order-level data, contact TransData Nexus.